Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)
China flag China · Delayed Price · Currency is CNY
6.71
-0.02 (-0.30%)
Nov 17, 2026, 3:00 PM CST

SHA:603229 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
757.05792.76795.29816.77764.55569.7
Revenue Growth
0.79%-0.32%-2.63%6.83%34.20%39.21%
Gross Profit
343.86404.61421.9444.36391.96308.41
Operating Income
-2.47117.21184.48244.54205.2152.2
Net Income
-4.53130.57206.79253.9235.38145.93
Earnings Per Share
-0.010.160.250.310.290.18
EPS Growth
--36.00%-19.36%5.84%59.45%57.55%

Revenue by Segment

Fiscal Year
FY 2025
Period EndingDec '25
Raw Materials and Intermediates
754.04
Fees for Technical Services
36.83
Pharmaceutical Preparation
1.89
Total
792.76

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
954.861,2271,0991,124612.87674.55
Total Debt
315.14456.65272.43303.17242.02109.93
Net Cash (Debt)
639.73769.86826.1821.06370.85564.62
Net Cash Growth
-15.69%-6.81%0.61%121.40%-34.32%-19.12%
Net Cash Per Share
0.810.941.001.000.460.71

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
65.23156.51177.93221.85120.57173.9
Capital Expenditures
-96.44-104.45-111.3-163.47-271.91-310.85
Free Cash Flow
-31.252.0666.6258.38-151.35-136.95
Free Cash Flow Growth
--21.85%14.12%---

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
45.42%51.04%53.05%54.40%51.27%54.14%
Operating Margin
-0.33%14.79%23.20%29.94%26.84%26.72%
Pretax Margin
-3.11%17.40%30.20%35.60%33.47%27.98%
Profit Margin
-0.60%16.47%26.00%31.09%30.79%25.61%
FCF Margin
-4.12%6.57%8.38%7.15%-19.80%-24.04%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.0640.0640.1000.0920.0570.037
Dividend Per Share Growth
-36.00%-36.00%8.58%61.30%53.91%62.72%
Dividend Yield
0.95%0.64%1.00%0.98%0.47%0.28%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-62.9340.1130.8640.6471.62
Forward PE
-34.2125.9522.5834.8754.34
P/FCF Ratio
-157.82124.50134.20--
PS Ratio
7.3110.3710.439.5912.5118.35